Navigation Links
Santarus to Webcast Analyst Day and Investor Briefing Presentation on May 13
Date:5/8/2009

SAN DIEGO, May 8 /PRNewswire-FirstCall/ -- Santarus, Inc. (Nasdaq: SNTS) today announced that a live audio webcast and accompanying slide presentation will be provided for its analyst day and investor briefing event "Santarus: What's New?".

Details of the event are as follows:

          What:     Santarus: What's New? Analyst Day and Investor Briefing

          When:     Wednesday, May 13, 2009 at 4:15 p.m. Eastern time

          Where:    www.santarus.com (under the Investor Relations link)

AGENDA

Welcome

Martha Hough, Vice President, Finance & Investor Relations, Santarus, Inc.

Santarus - What's New?

Gerald Proehl, President, Chief Executive Officer & Director, Santarus, Inc.

Commercial Update - ZEGERID(R)/GLUMETZA(R) and Overview of Lower GI Markets

William Denby, Senior Vice President, Commercial Operations, Santarus, Inc.

MMX(R) Technology - The Benefits of Targeted Delivery to the Colon

Dr. Luigi Moro, Chief Scientific Officer, Cosmo Pharmaceuticals

Inflammatory Bowel Disease - A New Horizon

Dr. Simon Travis, Consultant Gastroenterologist, John Radcliffe Hospital, Oxford, United Kingdom; Chairman of the Scientific Committee of the European Crohn's and Colitis Organization

Budesonide MMX(R) - Clinical Development Program in Ulcerative Colitis

Dr. E. David Ballard II, Senior Vice President, Clinical Research & Medical Affairs, Santarus, Inc.

Traveler's Diarrhea - #1 Health Risk for Travelers to Developing Countries

Dr. Robert Steffen, Professor Emeritus, University of Zurich Centre for Travel Medicine; Director, World Health Organization Collaborating Center for Travelers' Health

Rifamycin SV MMX(R) - Clinical Development Program in Traveler's Diarrhea

Dr. E. David Ballard II, Senior Vice President, Clinical Research & Medical Affairs, Santarus, Inc.

Summary/Question & Answer Session

Gerald Proehl, President, Chief Executive Officer & Director, Santarus, Inc.

          How:       Live over the Internet -- Simply log on to the Investor
                     Relations section of the company's Web site at
                     www.santarus.com

About Santarus

Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists and other targeted physicians. The company's current commercial efforts are focused on ZEGERID(R) (omeprazole/sodium bicarbonate) Capsules and Powder for Oral Suspension, which are indicated for the treatment of certain upper GI diseases and disorders, and on GLUMETZA(R) (metformin hydrochloride extended-release tablets), which are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. Santarus is also developing two late-stage lower GI product candidates, budesonide MMX(R) and rifamycin SV MMX(R) for the U.S. market. Budesonide MMX is being investigated in two multi-center Phase III clinical trials for the induction of remission of mild or moderate active ulcerative colitis. Rifamycin SV MMX has been investigated in a Phase II clinical program in traveler's diarrhea. More information about Santarus is available on the company's Web site at www.santarus.com.

Minimum Requirements to listen to broadcast:

The Windows Media Player software, downloadable free from http://www.microsoft.com/windows/windowsmedia/default.aspx and at least a 56Kbps connection to the Internet. If you experience problems listening to the webcast, send an e-mail to: webcast@multivu.com.


'/>"/>
SOURCE Santarus, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Mettler-Toledo International Inc. Announces Webcast of Presentation at Bank of America and Merrill Lynch Health Care Conference
2. Webcast Alert: Air Methods to Announce First Quarter 2009 Financial Results
3. Webcast Alert: Release of Economic Analysis Revealing $734 Billion in Savings Produced by Using Generic Medicines in 1999 - 2008
4. Gen-Probe to Webcast Two Upcoming Investor Presentations
5. Volcano Corporation Presentation at Bank of America/Merrill Lynch Conference to be Webcast
6. AMERIGROUP Corporation to Webcast Annual Meeting of Stockholders on May 7, 2009
7. Sunrise to Host Conference Call and Webcast to Discuss First-Quarter 2009 Financial Results
8. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2009 Financial Results on May 7, 2009
9. Thoratec Schedules First Quarter Conference Call, Webcast
10. Covance Inc. Invites You to Join the Webcast of Its First Quarter 2009 Financial Results Conference Call
11. Cepheid to Webcast Upcoming Financial Presentations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... ... ... PracticeMatch, a company that provides online resources , job boards ... like nurse practitioners and physician assistants , will conduct its first ... The online career fairs will allow job seekers to connect with healthcare employers from ...
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... FCPX LUT ... Editors can quickly and easily add washed color grades to footage. A LUT ... LUT changes every pixel’s color to the corresponding color indicated by the table. This ...
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... ... widely recognized community involvement program serving the people of Michigan. The new initiative ... almost 120 years at the very forefront of animal protection and welfare by ...
(Date:8/21/2017)... ... August 21, 2017 , ... San Diego physician and surgeon Dr. James Veltmeyer, ... announced his candidacy for the 52nd Congressional District currently held by Representative Scott Peters. ... to this country at age eleven after suffering homelessness and hardship in a distant ...
(Date:8/20/2017)... ... August 20, 2017 , ... HIPAA Solutions, ... System has assisted multiple clients in successfully passing audits such as Office ... Level 2 (AICPA SOC Level 2), and State Data Use Agreement Audits. ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Aug. 15, 2017  AOTI Inc. announced today that its fully ... has recently opened a New York City Office in ... its unique Topical Wound Oxygen (TWO 2 ) homecare therapy. This ... Commission for Health Care (ACHC) under the company,s DMEPOS accreditation for ... ...
(Date:8/8/2017)... -- BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused ... for the second quarter ended June 30, 2017. ... and to date: ... Company,s lead project, BL-8040: Announced plans ... novel stem cell mobilization treatment for autologous bone-marrow transplantation ...
(Date:8/7/2017)... , Aug. 7, 2017 Diplomat Pharmacy, Inc. (NYSE: ... Joel Saban as president, effective Aug. 7, 2017. ... has decided to pursue other interests and will serve as ... tenure, Paul has served us in multiple leadership roles since ... in Jun. 2015 and has provided decisive, strategic leadership which ...
Breaking Medicine Technology: